BioAgilytix Secures Significant New Investment from Global Investor Cinven to Fuel Continued Long-Term Growth

The Latest News from BioAgilytix

14 October, 2021

BioAgilytix Closes Acquisition of Australia-based 360biolabs®

Following final government approval, 360biolabs, a BioAgilytix company, adds world-class virology & immunology expertise and LC/MS/MS small molecule capabilities to the company, enabling support of bioanalytical services across all geographies…

Read More

4 October, 2021

BioAgilytix Announces New Partnership With CTI

Alliance to strengthen both companies’ ability to provide a seamless, full-service bioanalytical client experience across the full spectrum of lifecycle developmentDurham, NC, October 4, 2021 – BioAgilytix Labs, LLC (BioAgilytix), a leading…

Read More

26 August, 2021

For the 8th Time, BioAgilytix Named to Inc. 5000 Annual List of America’s Fastest-Growing Private Companies

Ranked No. 1939, With 3-Year Revenue Growth of 230 Percent DURHAM, NC, August 25, 2021 – BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research organization focused on supporting pharmaceutical…

Read More

18 August, 2021

MicroConstants to Join BioAgilytix Family

Highly complementary transaction strengthens BioAgilytix’s ability to support bioanalytical services across all major therapeutics in development; adds LC/MS/MS capabilities; and expands team of seasoned scientistsDurham, NC, August 18, 2021 –…

Read More

16 August, 2021

BioAgilytix to Purchase Australia-based 360biolabs®

Highly complementary transaction will strengthen company’s ability to support bioanalytical services across all stages, development capabilities and geographiesDurham, NC, August 16, 2021 – BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research laboratory focused…

Read More

12 July, 2021

BioAgilytix Welcomes Amanda L. Hays, Ph.D. To Team As Scientific Officer

DURHAM, North Carolina – BioAgilytix, a leading bioanalytical laboratory specializing in large molecule bioanalysis, welcomes Amanda L. Hays, Ph.D. to its team as Scientific Officer. Dr. Hays will provide consultative…

Read More

8 June, 2021

BioAgilytix Holds Ribbon Cutting to Celebrate Boston Lab Expansion, Additional Jobs and Tech Capabilities

BOSTON, Massachusetts – BioAgilytix, a leading bioanalytical laboratory specializing in large molecule bioanalysis, recently held a ribbon-cutting to celebrate the large-scale expansion of its leading-edge Boston laboratory. Located in the…

Read More

15 January, 2021

Carolina Business Review: Panel Interview with BioAgilytix CEO Jim Datin

In this episode of Carolina Business Review, BioAgilytix CEO Jim Datin gets interviewed by PBS Charlotte with the other panel guests Carl Blackstone and Brian Etheridge.

Read More

13 January, 2021

BioAgilytix Is Re-approved and Registered For The French Research Tax Credit (CIR)

HAMBURG, GERMANY: Jan 13, 2021 – BioAgilytix is thrilled to announce that our European lab in Hamburg, Germany is now CIR approved for 2020, 2021 and 2022, which allows us…

Read More